PILMAN » But http://www.tapanray.in A Tapan Ray Website Sun, 22 Mar 2026 10:59:18 +0000 en-US hourly 1 http://wordpress.org/?v=3.4.2 Supreme Court Intervened…But ‘Price Control’ needs striking a right balance between ‘Affordability’ and ‘Availability’ of medicines for Patients’ Sake http://www.tapanray.in/supreme-court-intervenedbut-price-control-needs-striking-a-right-balance-between-affordability-and-availability-of-medicines-for-patients/?utm_source=rss&utm_medium=rss&utm_campaign=supreme-court-intervenedbut-price-control-needs-striking-a-right-balance-between-affordability-and-availability-of-medicines-for-patients http://www.tapanray.in/supreme-court-intervenedbut-price-control-needs-striking-a-right-balance-between-affordability-and-availability-of-medicines-for-patients/#comments Mon, 08 Oct 2012 00:00:28 +0000 Tapan Ray http://tapanray.in/index.php/?p=1084 Continue reading →]]> http://www.tapanray.in/supreme-court-intervenedbut-price-control-needs-striking-a-right-balance-between-affordability-and-availability-of-medicines-for-patients/feed/ 0 Prescribing medicines by generic names…a good intent… but is it a practical proposition in India? http://www.tapanray.in/prescribing-medicines-by-generic-namesa-good-intent-but-is-it-a-practical-proposition-in-india/?utm_source=rss&utm_medium=rss&utm_campaign=prescribing-medicines-by-generic-namesa-good-intent-but-is-it-a-practical-proposition-in-india http://www.tapanray.in/prescribing-medicines-by-generic-namesa-good-intent-but-is-it-a-practical-proposition-in-india/#comments Mon, 06 Sep 2010 00:30:32 +0000 Tapan Ray http://tapanray.in/index.php/?p=378 Continue reading →]]> http://www.tapanray.in/prescribing-medicines-by-generic-namesa-good-intent-but-is-it-a-practical-proposition-in-india/feed/ 0 MCI has been dissolved but the guidelines to doctors must remain, carefully sanitizing the ambiguities within the process http://www.tapanray.in/mci-has-been-dissolved-but-the-guidelines-to-doctors-must-remain-carefully-sanitizing-the-ambiguities-within-the-process/?utm_source=rss&utm_medium=rss&utm_campaign=mci-has-been-dissolved-but-the-guidelines-to-doctors-must-remain-carefully-sanitizing-the-ambiguities-within-the-process http://www.tapanray.in/mci-has-been-dissolved-but-the-guidelines-to-doctors-must-remain-carefully-sanitizing-the-ambiguities-within-the-process/#comments Mon, 24 May 2010 00:30:06 +0000 Tapan Ray http://tapanray.in/index.php/?p=424 Continue reading →]]> http://www.tapanray.in/mci-has-been-dissolved-but-the-guidelines-to-doctors-must-remain-carefully-sanitizing-the-ambiguities-within-the-process/feed/ 0 Emerging markets and a robust oncology portfolio expected to be the future growth engine of the global pharmaceutical industry… but not without associated pricing pressures. http://www.tapanray.in/emerging-markets-and-a-robust-oncology-portfolio-expected-to-be-the-future-growth-engine-of-the-global-pharmaceutical-industry-but-not-without-associated-pricing-pressures/?utm_source=rss&utm_medium=rss&utm_campaign=emerging-markets-and-a-robust-oncology-portfolio-expected-to-be-the-future-growth-engine-of-the-global-pharmaceutical-industry-but-not-without-associated-pricing-pressures http://www.tapanray.in/emerging-markets-and-a-robust-oncology-portfolio-expected-to-be-the-future-growth-engine-of-the-global-pharmaceutical-industry-but-not-without-associated-pricing-pressures/#comments Thu, 08 Oct 2009 01:00:56 +0000 Tapan Ray http://tapanray.in/index.php/?p=760 Continue reading →]]> http://www.tapanray.in/emerging-markets-and-a-robust-oncology-portfolio-expected-to-be-the-future-growth-engine-of-the-global-pharmaceutical-industry-but-not-without-associated-pricing-pressures/feed/ 0